{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T03:53:05Z","timestamp":1743133985615,"version":"3.40.3"},"publisher-location":"Cham","reference-count":89,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030716110"},{"type":"electronic","value":"9783030716127"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-71612-7_9","type":"book-chapter","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T19:02:47Z","timestamp":1627498967000},"page":"247-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deciphering RNA Methylation in Cancer"],"prefix":"10.1007","author":[{"given":"Daniela","family":"Barros-Silva","sequence":"first","affiliation":[]},{"given":"Elena S.","family":"Martens-Uzunova","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/10409238.2020.1818685","volume":"55","author":"F Accornero","year":"2020","unstructured":"Accornero F, Ross RL, Alfonzo JD (2020) From canonical to modified nucleotides: balancing translation and metabolism. Crit Rev Biochem Mol Biol 55:525\u2013540","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0021-9258(18)70494-8","volume":"230","author":"M Adler","year":"1958","unstructured":"Adler M, Weissmann B, Gutman AB (1958) Occurrence of methylated purine bases in yeast ribonucleic acid. J Biol Chem 230:717\u2013723","journal-title":"J Biol Chem"},{"key":"9_CR3","unstructured":"ArrayStar Inc (2020) Limitations of m6A-seq and solutions of arraystar m6A single nucleotide arrays. https:\/\/www.arraystar.com\/reviews\/limitations-of-m6aseq-and-solutions-of-arraystar-m6a-single-nucleotide-arrays\/. Accessed 11 Nov 2020"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T (2020) Role of RNA modifications in cancer. Nat Rev Cancer 20:303\u2013322","journal-title":"Nat Rev Cancer"},{"key":"9_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1700006","volume":"3","author":"A Baudrimont","year":"2017","unstructured":"Baudrimont A, Voegeli S, Viloria EC et al (2017) Multiplexed gene control reveals rapid mRNA turnover. Sci Adv 3:e1700006","journal-title":"Sci Adv"},{"key":"9_CR6","doi-asserted-by":"publisher","unstructured":"Begik O, Lucas MC, Ramirez JM et al (2020) Decoding ribosomal RNA modification dynamics at single molecule resolution. bioRxiv. https:\/\/doi.org\/10.1101\/2020.07.06.189969","DOI":"10.1101\/2020.07.06.189969"},{"key":"9_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007147","volume":"4","author":"S Belin","year":"2009","unstructured":"Belin S, Beghin A, Solano-Gonz\u00e0lez E et al (2009) Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PLoS One 4:e7147","journal-title":"PLoS One"},{"key":"9_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/anie.201408362","volume":"54","author":"U Birkedal","year":"2015","unstructured":"Birkedal U, Christensen-Dalsgaard M, Krogh N et al (2015) Profiling of ribose methylations in RNA by high-throughput sequencing. Angew Chem Int Ed Engl 54:451\u2013455","journal-title":"Angew Chem Int Ed Engl"},{"issue":"D1","key":"9_CR9","doi-asserted-by":"publisher","first-page":"D303","DOI":"10.1093\/nar\/gkx1030","volume":"46","author":"P Boccaletto","year":"2018","unstructured":"Boccaletto P, Machnicka MA, Purta E et al (2018) MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res 46(D1):D303\u2013d307","journal-title":"Nucleic Acids Res"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"38617","DOI":"10.18632\/oncotarget.5775","volume":"6","author":"E Brighenti","year":"2015","unstructured":"Brighenti E, Trer\u00e9 D, Derenzini M (2015) Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility? Oncotarget 6:38617\u201338627","journal-title":"Oncotarget"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0022-2836(77)90285-6","volume":"114","author":"GG Brownlee","year":"1977","unstructured":"Brownlee GG, Cartwright EM (1977) Rapid gel sequencing of RNA by primed synthesis with reverse transcriptase. J Mol Biol 114:93\u2013117","journal-title":"J Mol Biol"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1073\/pnas.1921649117","volume":"117","author":"PM Bruno","year":"2020","unstructured":"Bruno PM, Lu M, Dennis KA et al (2020) The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning. Proc Natl Acad Sci USA 117:4053\u20134060","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bcp.2018.11.014","volume":"159","author":"F Catez","year":"2019","unstructured":"Catez F, Dalla Venezia N, Marcel V et al (2019) Ribosome biogenesis: an emerging druggable pathway for cancer therapeutics. Biochem Pharmacol 159:74\u201381","journal-title":"Biochem Pharmacol"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1021\/acs.analchem.8b04078","volume":"91","author":"B Chen","year":"2019","unstructured":"Chen B, Yuan B-F, Feng Y-Q (2019a) Analytical methods for deciphering RNA modifications. Anal Chem 91:743\u2013756","journal-title":"Anal Chem"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","volume":"18","author":"X-Y Chen","year":"2019","unstructured":"Chen X-Y, Zhang J, Zhu J-S (2019b) The role of m6A RNA methylation in human cancer. Mol Cancer 18:103","journal-title":"Mol Cancer"},{"issue":"4","key":"9_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.14701\/ahbps.2018.22.4.305","volume":"22","author":"SH Cho","year":"2018","unstructured":"Cho SH, Ha M, Cho YH et al (2018) ALKBH5 gene is a novel biomarker that predicts the prognosis of pancreatic cancer: a retrospective multicohort study. Ann Hepatobiliary Pancreat Surg 22(4):305\u2013309","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nmeth.4294","volume":"14","author":"Q Dai","year":"2017","unstructured":"Dai Q, Moshitch-Moshkovitz S, Han D et al (2017) Nm-seq maps 2\u2032-O-methylation sites in human mRNA with base precision. Nat Methods 14:695\u2013698","journal-title":"Nat Methods"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41556-019-0319-0","volume":"21","author":"S Delaunay","year":"2019","unstructured":"Delaunay S, Frye M (2019) RNA modifications regulating cell fate in cancer. Nat Cell Biol 21:552\u2013559","journal-title":"Nat Cell Biol"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","volume":"71","author":"R Desrosiers","year":"1974","unstructured":"Desrosiers R, Friderici K, Rottman F (1974) Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA 71:3971\u20133975","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/genes10020117","volume":"10","author":"DG Dimitrova","year":"2019","unstructured":"Dimitrova DG, Teysset L, Carr\u00e9 C (2019) RNA 2\u2032-O-methylation (Nm) modification in human diseases. Genes (Basel) 10:117","journal-title":"Genes (Basel)"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.jmb.2015.12.021","volume":"428","author":"JD Dinman","year":"2016","unstructured":"Dinman JD (2016) Pathways to specialized ribosomes: the Brussels lecture. J Mol Biol 428:2186\u20132194","journal-title":"J Mol Biol"},{"key":"9_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks698","volume":"40","author":"ZW Dong","year":"2012","unstructured":"Dong ZW, Shao P, Diao LT et al (2012) RTL-P: a sensitive approach for detecting sites of 2\u2032-O-methylation in RNA molecules. Nucleic Acids Res 40:e157","journal-title":"Nucleic Acids Res"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nsmb.3462","volume":"24","author":"RR Edupuganti","year":"2017","unstructured":"Edupuganti RR, Geiger S, Lindeboom RGH et al (2017) N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis. Nat Struct Mol Biol 24:870\u2013878","journal-title":"Nat Struct Mol Biol"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1093\/nar\/gkz736","volume":"47","author":"C Enroth","year":"2019","unstructured":"Enroth C, Poulsen LD, Iversen S et al (2019) Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing. Nucleic Acids Res 47:e126\u2013e126","journal-title":"Nucleic Acids Res"},{"key":"9_CR25","unstructured":"Epics Therapeutics (2020) EPICS invents medicines. https:\/\/www.epicstherapeutics.com\/. Accessed 8 Dec 2020"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"12934","DOI":"10.1073\/pnas.1707674114","volume":"114","author":"J Erales","year":"2017","unstructured":"Erales J, Marchand V, Panthu B et al (2017) Evidence for rRNA 2\u2032-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes. Proc Natl Acad Sci USA 114:12934\u201312939","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3389\/fphar.2019.01246","volume":"10","author":"JA Filippova","year":"2019","unstructured":"Filippova JA, Matveeva AM, Zhuravlev ES et al (2019) Are small nucleolar RNAs \u201cCRISPRable\u201d? A report on box C\/D small nucleolar RNA editing in human cells. Front Pharmacol 10:1246","journal-title":"Front Pharmacol"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nmeth.4577","volume":"15","author":"DR Garalde","year":"2018","unstructured":"Garalde DR, Snell EA, Jachimowicz D et al (2018) Highly parallel direct RNA sequencing on an array of nanopores. Nat Methods 15:201\u2013206","journal-title":"Nat Methods"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.4161\/15476286.2014.992280","volume":"11","author":"KW Gaston","year":"2014","unstructured":"Gaston KW, Limbach PA (2014) The identification and characterization of non-coding and coding RNAs and their modified nucleosides by mass spectrometry. RNA Biol 11:1568\u20131585","journal-title":"RNA Biol"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1093\/nar\/6.11.3443","volume":"6","author":"RC Gupta","year":"1979","unstructured":"Gupta RC, Randerath K (1979) Rapid print-readout technique for sequencing of RNA\u2019s containing modified nucleotides. Nucleic Acids Res 6:3443\u20133458","journal-title":"Nucleic Acids Res"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/15476286.2019.1670598","volume":"17","author":"J Hebras","year":"2020","unstructured":"Hebras J, Krogh N, Marty V et al (2020) Developmental changes of rRNA ribose methylations in the mouse. RNA Biol 17:150\u2013164","journal-title":"RNA Biol"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"5669","DOI":"10.1038\/s41467-019-13684-3","volume":"10","author":"M Helm","year":"2019","unstructured":"Helm M, Lyko F, Motorin Y (2019) Limited antibody specificity compromises epitranscriptomic analyses. Nat Commun 10:5669","journal-title":"Nat Commun"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.1073\/pnas.81.18.5667","volume":"81","author":"S Horowitz","year":"1984","unstructured":"Horowitz S, Horowitz A, Nilsen TW et al (1984) Mapping of N6-methyladenosine residues in bovine prolactin mRNA. Proc Natl Acad Sci USA 81:5667\u20135671","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-cancerbio-030419-033357","volume":"4","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Deng X et al (2020) RNA modifications in cancer: functions, mechanisms, and therapeutic implications. Ann Rev Cancer Biol 4:221\u2013240","journal-title":"Ann Rev Cancer Biol"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"12930","DOI":"10.1039\/C7CC07699A","volume":"53","author":"M Imanishi","year":"2017","unstructured":"Imanishi M, Tsuji S, Suda A et al (2017) Detection of N 6-methyladenosine based on the methyl-sensitivity of MazF RNA endonuclease. Chem Commun 53:12930\u201312933","journal-title":"Chem Commun"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/nar\/gkw810","volume":"45","author":"D Incarnato","year":"2017","unstructured":"Incarnato D, Anselmi F, Morandi E et al (2017) High-throughput single-base resolution mapping of RNA 2\u2032-O-methylated residues. Nucleic Acids Res 45:1433\u20131441","journal-title":"Nucleic Acids Res"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4161\/rna.7.2.11468","volume":"7","author":"S Kellner","year":"2010","unstructured":"Kellner S, Burhenne J, Helm M (2010) Detection of RNA modifications. RNA Biol 7:237\u2013247","journal-title":"RNA Biol"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-45636-8","volume":"9","author":"CM Klinge","year":"2019","unstructured":"Klinge CM, Piell KM, Tooley CS et al (2019) HNRNPA2\/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells. Sci Rep 9:1\u201322","journal-title":"Sci Rep"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"7884","DOI":"10.1093\/nar\/gkw482","volume":"44","author":"N Krogh","year":"2016","unstructured":"Krogh N, Jansson MD, H\u00e4fner SJ et al (2016) Profiling of 2\u2032-O-Me in human rRNA reveals a subset of fractionally modified positions and provides evidence for ribosome heterogeneity. Nucleic Acids Res 44:7884\u20137895","journal-title":"Nucleic Acids Res"},{"key":"9_CR40","doi-asserted-by":"crossref","unstructured":"Leger A, Amaral PP, Pandolfini L et al (2019) RNA modifications detection by comparative nanopore direct RNA sequencing. BioRxiv:843136","DOI":"10.1101\/843136"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-genom-090413-025405","volume":"15","author":"S Li","year":"2014","unstructured":"Li S, Mason CE (2014) The pivotal regulatory landscape of RNA modifications. Ann Rev Genomics Hum Genet 15:127\u2013150","journal-title":"Ann Rev Genomics Hum Genet"},{"key":"9_CR42","doi-asserted-by":"crossref","unstructured":"Liang J, Wen J, Huang Z et al (2019) Small nucleolar RNAs: insight into their function in Cancer. Front Oncol 9(587)","DOI":"10.3389\/fonc.2019.00587"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature09688","volume":"469","author":"J Lin","year":"2011","unstructured":"Lin J, Lai S, Jia R et al (2011) Structural basis for site-specific ribose methylation by box C\/D RNA protein complexes. Nature 469:559\u2013563","journal-title":"Nature"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-biochem-062917-011942","volume":"87","author":"J Lin","year":"2018","unstructured":"Lin J, Zhou D, Steitz TA et al (2018) Ribosome-targeting antibiotics: modes of action, mechanisms of resistance, and implications for drug design. Annu Rev Biochem 87:451\u2013478","journal-title":"Annu Rev Biochem"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nmeth.3453","volume":"12","author":"B Linder","year":"2015","unstructured":"Linder B, Grozhik AV, Olarerin-George AO et al (2015) Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods 12:767\u2013772","journal-title":"Nat Methods"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1261\/rna.041178.113","volume":"19","author":"N Liu","year":"2013","unstructured":"Liu N, Parisien M, Dai Q et al (2013) Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA. RNA 19:1848\u20131856","journal-title":"RNA"},{"key":"9_CR47","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1038\/s41467-019-11713-9","volume":"10","author":"H Liu","year":"2019","unstructured":"Liu H, Begik O, Lucas MC et al (2019) Accurate detection of m6A RNA modifications in native RNA sequences. Nat Commun 10:4079","journal-title":"Nat Commun"},{"key":"9_CR48","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/genes9110552","volume":"9","author":"J Lobo","year":"2018","unstructured":"Lobo J, Barros-Silva D, Henrique R et al (2018) The emerging role of epitranscriptomics in cancer: focus on urological tumors. Genes (Basel) 9:552","journal-title":"Genes (Basel)"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1261\/rna.072785.119","volume":"26","author":"DA Lorenz","year":"2020","unstructured":"Lorenz DA, Sathe S, Einstein JM et al (2020) Direct RNA sequencing enables m6A detection in endogenous transcript isoforms at base-specific resolution. RNA 26:19\u201328","journal-title":"RNA"},{"key":"9_CR50","doi-asserted-by":"crossref","unstructured":"Maden BE (2001) Mapping 2\u2032-O-methyl groups in ribosomal RNA. Methods (San Diego, Calif) 25:374\u2013382","DOI":"10.1006\/meth.2001.1250"},{"key":"9_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0300-9084(96)88100-4","volume":"77","author":"BE Maden","year":"1995","unstructured":"Maden BE, Corbett ME, Heeney PA et al (1995) Classical and novel approaches to the detection and localization of the numerous modified nucleotides in eukaryotic ribosomal RNA. Biochimie 77:22\u201329","journal-title":"Biochimie"},{"key":"9_CR52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccr.2013.08.013","volume":"24","author":"V Marcel","year":"2013","unstructured":"Marcel V, Ghayad SE, Belin S et al (2013) p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell 24:318\u2013330","journal-title":"Cancer Cell"},{"key":"9_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw547","volume":"44","author":"V Marchand","year":"2016","unstructured":"Marchand V, Blanloeil-Oillo F, Helm M et al (2016) Illumina-based RiboMethSeq approach for mapping of 2\u2032-O-Me residues in RNA. Nucleic Acids Res 44:e135","journal-title":"Nucleic Acids Res"},{"key":"9_CR54","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","volume":"33","author":"KD Meyer","year":"2017","unstructured":"Meyer KD, Jaffrey SR (2017) Rethinking m(6)A readers, writers, and erasers. Ann Rev Cell Dev Biol 33:319\u2013342","journal-title":"Ann Rev Cell Dev Biol"},{"key":"9_CR55","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, Saletore Y, Zumbo P et al (2012) Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons. Cell 149:1635\u20131646","journal-title":"Cell"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/genes10010035","volume":"10","author":"Y Motorin","year":"2019","unstructured":"Motorin Y, Helm M (2019) Methods for RNA modification mapping using deep sequencing: established and new emerging technologies. Genes (Basel) 10:35","journal-title":"Genes (Basel)"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/genes9120642","volume":"9","author":"Y Motorin","year":"2018","unstructured":"Motorin Y, Marchand V (2018) Detection and analysis of RNA ribose 2\u2032-O-methylations: challenges and solutions. Genes (Basel) 9:642","journal-title":"Genes (Basel)"},{"key":"9_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0076-6879(07)25002-5","volume":"425","author":"Y Motorin","year":"2007","unstructured":"Motorin Y, Muller S, Behm-Ansmant I et al (2007) Identification of modified residues in RNAs by reverse transcription-based methods. Methods Enzymol 425:21\u201353","journal-title":"Methods Enzymol"},{"key":"9_CR59","doi-asserted-by":"crossref","unstructured":"Nagarajan A, Janostiak R, Wajapeyee N (2019) Dot blot analysis for measuring global N 6-methyladenosine modification of RNA. In: Epitranscriptomics. Springer, pp 263\u2013271","DOI":"10.1007\/978-1-4939-8808-2_20"},{"key":"9_CR60","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.apsb.2018.06.001","volume":"8","author":"Y Niu","year":"2018","unstructured":"Niu Y, Wan A, Lin Z et al (2018) N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development. Acta Pharm Sin B 8:833\u2013843","journal-title":"Acta Pharm Sin B"},{"key":"9_CR61","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1182\/blood.2019004121","volume":"135","author":"C Pauli","year":"2020","unstructured":"Pauli C, Liu Y, Rohde C et al (2020) Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation. Blood 135:2059\u20132070","journal-title":"Blood"},{"key":"9_CR62","doi-asserted-by":"crossref","unstructured":"Quemener AM, Bachelot L, Forestier A et al (2020) The powerful world of antisense oligonucleotides: from bench to bedside. Wiley Interdiscip Rev RNA e1594","DOI":"10.1002\/wrna.1594"},{"key":"9_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2199-3-1","volume":"3","author":"A Rebane","year":"2002","unstructured":"Rebane A, Roomere H, Metspalu A (2002) Locations of several novel 2\u2032-O-methylated nucleotides in human 28S rRNA. BMC Mol Biol 3:1\u20135","journal-title":"BMC Mol Biol"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fgene.2018.00243","volume":"9","author":"G Romano","year":"2018","unstructured":"Romano G, Veneziano D, Nigita G et al (2018) RNA methylation in ncRNA: classes, detection, and molecular associations. Front Genet 9:243","journal-title":"Front Genet"},{"key":"9_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/gb-2012-13-10-175","volume":"13","author":"Y Saletore","year":"2012","unstructured":"Saletore Y, Meyer K, Korlach J et al (2012) The birth of the Epitranscriptome: deciphering the function of RNA modifications. Genome Biol 13:175","journal-title":"Genome Biol"},{"key":"9_CR66","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1080\/15476286.2016.1251543","volume":"14","author":"S Schwartz","year":"2017","unstructured":"Schwartz S, Motorin Y (2017) Next-generation sequencing technologies for detection of modified nucleotides in RNAs. RNA Biol 14:1124\u20131137","journal-title":"RNA Biol"},{"key":"9_CR67","doi-asserted-by":"publisher","first-page":"11490","DOI":"10.1038\/s41598-017-09734-9","volume":"7","author":"S Sharma","year":"2017","unstructured":"Sharma S, Marchand V, Motorin Y et al (2017) Identification of sites of 2\u2032-O-methylation vulnerability in human ribosomal RNAs by systematic mapping. Sci Rep 7:11490","journal-title":"Sci Rep"},{"key":"9_CR68","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40364-020-00203-6","volume":"8","author":"H Shen","year":"2020","unstructured":"Shen H, Lan Y, Zhao Y et al (2020) The emerging roles of N6-methyladenosine RNA methylation in human cancers. Biomark Res 8:24","journal-title":"Biomark Res"},{"key":"9_CR69","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1080\/15476286.2016.1259781","volume":"14","author":"KE Sloan","year":"2017","unstructured":"Sloan KE, Warda AS, Sharma S et al (2017) Tuning the ribosome: the influence of rRNA modification on eukaryotic ribosome biogenesis and function. RNA Biol 14:1138\u20131152","journal-title":"RNA Biol"},{"key":"9_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00300-w","volume":"5","author":"H Song","year":"2020","unstructured":"Song H, Liu D, Dong S et al (2020) Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications. Signal Transduct Targeted Ther 5:1\u201316","journal-title":"Signal Transduct Targeted Ther"},{"key":"9_CR71","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1093\/nar\/gks144","volume":"40","author":"JE Squires","year":"2012","unstructured":"Squires JE, Patel HR, Nousch M et al (2012) Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res 40:5023\u20135033","journal-title":"Nucleic Acids Res"},{"key":"9_CR72","unstructured":"Storm Therapeutics Ltd (2019) RNA epigenetics is coming of age. https:\/\/www.stormtherapeutics.com\/news-events\/storm-in-the-news\/rna-epigenetics-is-coming-of-age\/. Accessed 1 Dec 2020"},{"key":"9_CR73","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.bmc.2019.03.057","volume":"27","author":"J Sztuba-Solinska","year":"2019","unstructured":"Sztuba-Solinska J, Chavez-Calvillo G, Cline SE (2019) Unveiling the druggable RNA targets and small molecule therapeutics. Bioorg Med Chem 27:2149\u20132165","journal-title":"Bioorg Med Chem"},{"key":"9_CR74","first-page":"621","volume":"52","author":"K Taketo","year":"2018","unstructured":"Taketo K, Konno M, Asai A et al (2018) The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. Int J Oncol 52:621\u2013629","journal-title":"Int J Oncol"},{"key":"9_CR75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127962","volume-title":"Pharmacological inhibition of the RNA m6A writer METTL3 as a novel therapeutic strategy for acute myeloid leukemia","author":"K Tzelepis","year":"2019","unstructured":"Tzelepis K, De Braekeleer E, Yankova E et al (2019) Pharmacological inhibition of the RNA m6A writer METTL3 as a novel therapeutic strategy for acute myeloid leukemia. American Society of Hematology, Washington, DC"},{"key":"9_CR76","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1261\/rna.076026.120","volume":"26","author":"F Weichmann","year":"2020","unstructured":"Weichmann F, Hett R, Schepers A et al (2020) Validation strategies for antibodies targeting modified ribonucleotides. RNA 26:1489\u20131506","journal-title":"RNA"},{"key":"9_CR77","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1039\/C5AN01797A","volume":"141","author":"C Wetzel","year":"2016","unstructured":"Wetzel C, Limbach PA (2016) Mass spectrometry of modified RNAs: recent developments. Analyst 141:16\u201323","journal-title":"Analyst"},{"key":"9_CR78","doi-asserted-by":"crossref","unstructured":"Wiener D, Schwartz S (2020) The epitranscriptome beyond m6A. Nat Rev Genet 1\u201313","DOI":"10.1038\/s41576-020-00295-8"},{"key":"9_CR79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12943-020-01201-w","volume":"19","author":"H Wu","year":"2020","unstructured":"Wu H, Qin W, Lu S et al (2020) Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2\u2032-O-methylation via NOP58 recruitment in colorectal cancer. Mol Cancer 19:95","journal-title":"Mol Cancer"},{"key":"9_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168873","volume":"11","author":"J Yang","year":"2016","unstructured":"Yang J, Sharma S, Watzinger P et al (2016) Mapping of complete set of ribose and base modifications of yeast rRNA by RP-HPLC and mung bean nuclease assay. PLoS One 11:e0168873","journal-title":"PLoS One"},{"key":"9_CR81","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12935-020-01445-y","volume":"20","author":"G Yang","year":"2020","unstructured":"Yang G, Sun Z, Zhang N (2020) Reshaping the role of m6A modification in cancer transcriptome: a review. Cancer Cell Int 20:353","journal-title":"Cancer Cell Int"},{"key":"9_CR82","first-page":"324","volume":"3","author":"YT Yu","year":"1997","unstructured":"Yu YT, Shu MD, Steitz JA (1997) A new method for detecting sites of 2\u2032-O-methylation in RNA molecules. RNA 3:324\u2013331","journal-title":"RNA"},{"key":"9_CR83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrc2559","volume":"9","author":"J Zhang","year":"2009","unstructured":"Zhang J, Yang PL, Gray NS (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9:28\u201339","journal-title":"Nat Rev Cancer"},{"key":"9_CR84","first-page":"1504","volume":"9","author":"D Zhang","year":"2019","unstructured":"Zhang D, Zhou J, Gao J et al (2019) Targeting snoRNAs as an emerging method of therapeutic development for cancer. Am J Cancer Res 9:1504\u20131516","journal-title":"Am J Cancer Res"},{"key":"9_CR85","first-page":"2156","volume":"9","author":"X Zhao","year":"2019","unstructured":"Zhao X, Cui L (2019) Development and validation of a m6A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma. Am J Cancer Res 9:2156","journal-title":"Am J Cancer Res"},{"key":"9_CR86","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1261\/rna.7110804","volume":"10","author":"X Zhao","year":"2004","unstructured":"Zhao X, Yu YT (2004) Detection and quantitation of RNA base modifications. RNA 10:996\u20131002","journal-title":"RNA"},{"key":"9_CR87","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ncb3563","volume":"19","author":"F Zhou","year":"2017","unstructured":"Zhou F, Liu Y, Rohde C et al (2017) AML1-ETO requires enhanced C\/D box snoRNA\/RNP formation to induce self-renewal and leukaemia. Nat Cell Biol 19:844\u2013855","journal-title":"Nat Cell Biol"},{"key":"9_CR88","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-020-01216-3","volume":"19","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Lv J, Yu H et al (2020) Mechanism of RNA modification N6-methyladenosine in human cancer. Mol Cancer 19:104","journal-title":"Mol Cancer"},{"key":"9_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1585-2","volume":"10","author":"L Zhu","year":"2019","unstructured":"Zhu L, Zhu Y, Han S et al (2019) Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer. Cell Death Dis 10:1\u201316","journal-title":"Cell Death Dis"}],"container-title":["RNA Technologies","Epitranscriptomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-71612-7_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T16:09:59Z","timestamp":1699286999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-71612-7_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030716110","9783030716127"],"references-count":89,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-71612-7_9","relation":{},"ISSN":["2197-9731","2197-9758"],"issn-type":[{"type":"print","value":"2197-9731"},{"type":"electronic","value":"2197-9758"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"29 July 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}